Resource Library

This section provides immediate access to all of the resources that we have on our site in both HTML and PDF formats.

• For the Public
• For Health Care Professionals
• Medical and Treatment Guidelines
• For Educators
• Hepatitis C Prevention, Support & Research Program
• Articles by Section Members

---

For the Public

• Healthy Living with Hepatitis C (Booklet) , Canadian Liver Foundation
• It's Your Health - Hepatitis C
• Hepatitis C Get the Facts
  
• Hepatitis C & Injection Drug Use
  - PDF Version (220 KB)
• Hepatitis C & Injection Drug Use - A Focus On Youth
  - PDF Version (221 KB)

For Health Care Professionals

• Epi-Update - Hepatitis C Virus Infection in Canadian Street Youth (1999 – 2005)
• Epi-Update - Hepatitis C Virus Infection among Injecting Drug Users (IDU) in Canada: Results from I-track (2003-2005)
• Hepatitis C Virus Infection in Canadian Street Youth: The Role of Injection Drug Use
• Hepatitis C Information for Health Professionals
• The Effectiveness of Bleach in the Prevention of Hepatitis C Transmission - Final Report
• A Study to Characterize the Epidemiology of Hepatitis C Infection in Canada, 2002. Final Report
• Hepatitis C Prevention: An Examination of Current International Evidence (February 2002)
  - PDF Version (1,113 KB)
• The Effectiveness of Harm Reduction Strategies in Modifying Hepatitis C Infection among Injection Drug Users in Canada (2001)
• Estimating the number of persons co-infected with Hepatitis C virus and Human Immunodeficiency virus in Canada (March 2001)
  - PDF Version (694 KB)
• Profile of Hepatitis C & Injection Drug Use in Canada (September 2000)
  - PDF Version (99 KB)
• Estimating the number of blood transfusion recipients infected by hepatitis C virus in Canada, 1960-85 and 1990-92. Report to Health Canada (June 1998)
  - PDF Version (240 KB)

Medical and Treatment Guidelines

• Primary Care Management of Chronic Hepatitis C - Professional Desk Reference 2009
  Pinette GD, Cox JJ, Heathcote J, Moore L, Adamowski K, Riehl G.

  • To order copies of this reference, please fill out the attached form and fax your order to the Public Health Agency of Canada at (613) 941-7563.
• Management and Treatment of Hepatitis C Virus in Patients with HIV and Hepatitis C Virus Coinfection: A Practical Guide for Health Care Professionals. The Canadian Journal of Infectious Diseases & Medical Microbiology. Sept/Oct 2007;18(5):293-303.
• Management of Chronic Hepatitis C: Consensus Guidelines, Canadian Consensus Guidelines . Sherman M, Shafran S, Burak K, Doucette K, Wong W, Girgrah N, Yoshida E, Renner E, Wong P, Deschênes M. Can J Gastroenterol Vol 21 Suppl C June 2007.
  
• Nutrition Tips for People with Hepatitis C (September 2003):
  Helping You Feel Your Best!
  - PDF Version (370 KB)
  Dealing With Discomforts
  - PDF Version (365 KB)
• Hepatitis C: A Nursing Guide
  - PDF Version (185 KB)
• Infection Control Guidelines - Prevention and Control of Occupational Infections in Health Care
  CCDR Volume 28S1, March 2002
• Management Guidelines for the HCV-HIV Co-infected Adult
  
• Reproductive Care of Women Living with Hep C Infection
  - PDF Version (156 KB)

For Educators

• Hepatitis C: Intervention Programming for Youth at Risk - Final Consolidated Report
• Responding to an Emergency: Education, Advocacy and Community Care by a Peer-driven Organization of Drug Users (December 2001)
  - PDF Version (1,751 KB)
• Harm reduction and injection drug use: An international comparative study of contextual factors influencing the development and implementation of relevant policies and programs (September 2001)
  - PDF Version (860 KB)
• Special Report on Youth, Piercing, Tattooing and Hepatitis C (March 2001)
  - PDF Version (583KB)
• Mediums to Reach Injection Drug Users - A Discussion Paper (September 2000)
  - PDF Version (64 KB)
• Resources for Hepatitis C & Injection Drug Use - A Needs Assessment (July 2000)
  - PDF Version (99 KB)
• Angus Reid Survey (January 2000)
  - PDF Version (93 KB)

Hepatitis C Prevention, Support & Research Program

• For publications pertaining to the Program, please click here.

Articles by Section Members

• Jayaraman GC, Lee B, Singh AE, Preiksaitis JK. Trends in testing behaviours for hepatitis C virus infection and associated determinants: results from population-based laboratory surveillance in Alberta, Canada (1998-2001). J Viral Hepat. April 2007;14(4):249-254.
• Wu HX, Wu J, Wong T, Donaldson T, Dinner K, Andonov A, Ip Chan J, Moffat B, Baptiste B, Furseth J, Poliquin D, Bolesnikov G, Giulivi A, Paton S. Enhanced surveillance of newly acquired hepatitis C virus infection in Canada, 1998 to 2004 . Scand J Infect Dis 2006;38(6-7):482-9.
• Wu H-X, Wu J, Wong T, Andonov A, Li Q, Dinner K, Donaldson T, Paton S, Enhanced Hepatitis Strain Surveillance System (c/o MHuard). Incidence and risk factors for newly acquired hepatitis C virus infection among Aboriginal versus non-Aboriginal Canadians in six regions, 1999-2004. Eur J Clin Microbiol Infect Dis. Mar 2006;26(3):167-174.
  
• Wong T, Lee SS. Review. Hepatitis C: a review for primary care physicians . CMAJ Feb 28, 2006; 174(5):640-659.
  Correction : In the article, the correct sentence is "For analgesia, small doses of ASA (< 2 g/d) are vastly preferable to NSAIDs in patients with liver disease." The medication is acetaminophen instead of ASA as printed.
• Dinner K, Donaldson T, Potts J, Sirna J, Wong T. Hepatitis C: a public health perspective and related implications for physicians . Royal College Outlook, Fall 2005;2(3):20:22.